中国药业
中國藥業
중국약업
CHINA PHARMACEUTICALS
2015年
10期
23-25,26
,共4页
郝彦明%王洪震%贾正平%徐又佳%俞晨
郝彥明%王洪震%賈正平%徐又佳%俞晨
학언명%왕홍진%가정평%서우가%유신
甲基强的松龙%促红细胞生成素%星形胶质细胞%缺营养%联合用药
甲基彊的鬆龍%促紅細胞生成素%星形膠質細胞%缺營養%聯閤用藥
갑기강적송룡%촉홍세포생성소%성형효질세포%결영양%연합용약
methylprednisolone%erythropoietin%astrocytes%nulli-nutrition%combined medication
目的:研究甲基强的松龙(MPSS)与促红细胞生成素(EPO)联合应用对体外培养的原代星形胶质细胞的作用。方法采用出生3 d内SD新生鼠的大脑制成细胞悬浊液后,以含15%胎牛血清的DMEM培养液培养,摇床后逐渐传代、纯化星形胶质细胞,磷酸盐缓冲液(PBS)代替培养基模拟缺营养模型3 h后即刻分别加入MPSS 10μmol/L,EPO 10 U/L,MPSS 10μmol/L﹢EPO 10 U/L,分别继续培养3 d,采用免疫荧光技术鉴定星形胶质细胞,MTT法检测细胞的增殖活性和凋亡,聚合酶链式反应(PCR)技术测定细胞胶质纤维酸性蛋白( GFAP ) mRNA表达水平。结果星形胶质细胞摇床后传至第3代,经鉴定细胞纯度达95%以上;缺营养3 h后部分细胞形态变圆甚至死亡漂浮于正常细胞表面;正常组和损伤组分别加入MPSS,EPO,MPSS﹢EPO 3 d后,损伤组细胞活性与GFAP mRNA表达水平均明显升高( P﹤0.05),且MPSS和EPO联合应用与单用MPSS、单用EPO相比,细胞活性与GFAP mRNA表达水平明显升高( P﹤0.05),但正常组无明显变化( P﹥0.05)。结论适当剂量的MPSS与EPO联合应用对缺营养损伤星形胶质细胞有显著的保护作用,且与单用MPSS、单用EPO相比有显著性差异,但对正常星形胶质细胞无显著的保护作用。
目的:研究甲基彊的鬆龍(MPSS)與促紅細胞生成素(EPO)聯閤應用對體外培養的原代星形膠質細胞的作用。方法採用齣生3 d內SD新生鼠的大腦製成細胞懸濁液後,以含15%胎牛血清的DMEM培養液培養,搖床後逐漸傳代、純化星形膠質細胞,燐痠鹽緩遲液(PBS)代替培養基模擬缺營養模型3 h後即刻分彆加入MPSS 10μmol/L,EPO 10 U/L,MPSS 10μmol/L﹢EPO 10 U/L,分彆繼續培養3 d,採用免疫熒光技術鑒定星形膠質細胞,MTT法檢測細胞的增殖活性和凋亡,聚閤酶鏈式反應(PCR)技術測定細胞膠質纖維痠性蛋白( GFAP ) mRNA錶達水平。結果星形膠質細胞搖床後傳至第3代,經鑒定細胞純度達95%以上;缺營養3 h後部分細胞形態變圓甚至死亡漂浮于正常細胞錶麵;正常組和損傷組分彆加入MPSS,EPO,MPSS﹢EPO 3 d後,損傷組細胞活性與GFAP mRNA錶達水平均明顯升高( P﹤0.05),且MPSS和EPO聯閤應用與單用MPSS、單用EPO相比,細胞活性與GFAP mRNA錶達水平明顯升高( P﹤0.05),但正常組無明顯變化( P﹥0.05)。結論適噹劑量的MPSS與EPO聯閤應用對缺營養損傷星形膠質細胞有顯著的保護作用,且與單用MPSS、單用EPO相比有顯著性差異,但對正常星形膠質細胞無顯著的保護作用。
목적:연구갑기강적송룡(MPSS)여촉홍세포생성소(EPO)연합응용대체외배양적원대성형효질세포적작용。방법채용출생3 d내SD신생서적대뇌제성세포현탁액후,이함15%태우혈청적DMEM배양액배양,요상후축점전대、순화성형효질세포,린산염완충액(PBS)대체배양기모의결영양모형3 h후즉각분별가입MPSS 10μmol/L,EPO 10 U/L,MPSS 10μmol/L﹢EPO 10 U/L,분별계속배양3 d,채용면역형광기술감정성형효질세포,MTT법검측세포적증식활성화조망,취합매련식반응(PCR)기술측정세포효질섬유산성단백( GFAP ) mRNA표체수평。결과성형효질세포요상후전지제3대,경감정세포순도체95%이상;결영양3 h후부분세포형태변원심지사망표부우정상세포표면;정상조화손상조분별가입MPSS,EPO,MPSS﹢EPO 3 d후,손상조세포활성여GFAP mRNA표체수평균명현승고( P﹤0.05),차MPSS화EPO연합응용여단용MPSS、단용EPO상비,세포활성여GFAP mRNA표체수평명현승고( P﹤0.05),단정상조무명현변화( P﹥0.05)。결론괄당제량적MPSS여EPO연합응용대결영양손상성형효질세포유현저적보호작용,차여단용MPSS、단용EPO상비유현저성차이,단대정상성형효질세포무현저적보호작용。
Objective To study the effect of methylprednisolone(MPSS) combined with erythropoietin(EPO) to in vitro cultured primary astrocytes(AST). Methods The cell suspension was prepared by using the cerebrum of neonatal rats within 3 d of birth,cultured by the DMEM culture solution containing 15% fetal calf serum,gradually passaged after shaking for purifying astrocytes. After simulating nulli-nutrition model for 3 h by phosphate buffer solution(PBS) for substituting medium,MPSS 10 μmol/L,EPO 10 U/L and MPSS 10 U/L plus EPO 10 U/L were immediately added and the continuous culture for 3 d was performed. Astrocytes were identified by the immunofluorescent technique;the proliferation activity and apoptosis of astrocytes were detected by MTT;the expression level of GFAP mRNA was detected by PCR. Results Astrocytes were passaged to the third generation after shaking,the astrocytes purity reached more than 95% by identification;part of astrocytes became round in morphology and even died after nulli-nutrition for 3 h;after 3 d of applying MPSS,EPO and MPSS plus EPO in the normal group and the damage group,both cytoactive and expression level of GFAP mRNA in the damage group were significantly increased ( P ﹤ 0. 05 ) ,moreover compare with the single application of MPSS or EPO,the cytoactive and GFAP mRNA expression level in the combined application of MPSS and EPO were significantly increased( P ﹤ 0. 05),but no obvious change was found in the normal group( P ﹥ 0. 05). Conclusion The combined application of proper dose of MPSS and EPO has obviously protection effect on nulli-nutrition damaged astrocytes,moreover has significant difference compared with the single appli-cation of MPSS or EPO,but has no obvious protective effect on normal astrocytes.